Azithromycin Combination Therapy for the Treatment of Uncomplicated Falciparum Malaria in Bangladesh
Azithromycin Combination Therapy for the Treatment of Uncomplicated Falciparum Malaria in Bangladesh: An Open Label Randomized Controlled Trial
Sponsor: Armed Forces Research Institute of Medical Sciences, Thailand
A PHASE2 clinical study on Uncomplicated Falciparum Malaria, this trial is completed. The trial is conducted by Armed Forces Research Institute of Medical Sciences, Thailand and has accumulated 6 data snapshots since 2006. Infectious disease trials contribute critical data for public health response and treatment development.
Change History
6 versions recorded-
Sep 2025 — Present [monthly]
Completed PHASE2
-
Sep 2024 — Sep 2025 [monthly]
Completed PHASE2
-
Jul 2024 — Sep 2024 [monthly]
Completed PHASE2
-
Jan 2021 — Jul 2024 [monthly]
Completed PHASE2
-
Jun 2018 — Jan 2021 [monthly]
Completed PHASE2
▶ Show 1 earlier version
-
Jan 2017 — Jun 2018 [monthly]
Completed PHASE2
First recorded
Aug 2006
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Armed Forces Research Institute of Medical Sciences, Thailand
- International Centre for Diarrhoeal Disease Research, Bangladesh
- Medical University of Vienna
For direct contact, visit the study record on ClinicalTrials.gov .
Study Locations
- • Bāndarban, Bangladesh